PMC:7417114 / 1157-1331 JSONTXT

Annnotations TAB JSON ListView MergeView

    LitCovid-PD-CLO

    {"project":"LitCovid-PD-CLO","denotations":[{"id":"T8","span":{"begin":22,"end":30},"obj":"http://purl.obolibrary.org/obo/CLO_0001658"}],"text":"in terms of antiviral activity and alleviation of disease symptoms, however drug combination is also an option for inhibitors with optimal pharmacokinetic properties that all"}

    LitCovid-PD-CHEBI

    {"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T7","span":{"begin":12,"end":21},"obj":"Chemical"},{"id":"T8","span":{"begin":76,"end":80},"obj":"Chemical"},{"id":"T9","span":{"begin":115,"end":125},"obj":"Chemical"}],"attributes":[{"id":"A7","pred":"chebi_id","subj":"T7","obj":"http://purl.obolibrary.org/obo/CHEBI_22587"},{"id":"A8","pred":"chebi_id","subj":"T8","obj":"http://purl.obolibrary.org/obo/CHEBI_23888"},{"id":"A9","pred":"chebi_id","subj":"T9","obj":"http://purl.obolibrary.org/obo/CHEBI_35222"}],"text":"in terms of antiviral activity and alleviation of disease symptoms, however drug combination is also an option for inhibitors with optimal pharmacokinetic properties that all"}

    LitCovid-PMC-OGER-BB

    {"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T21","span":{"begin":76,"end":80},"obj":"CHEBI:23888;CHEBI:23888"},{"id":"T22","span":{"begin":115,"end":125},"obj":"CHEBI:35222;CHEBI:35222"},{"id":"T23","span":{"begin":139,"end":154},"obj":"CHEBI:52217;CHEBI:52217"},{"id":"T1907","span":{"begin":76,"end":80},"obj":"CHEBI:23888;CHEBI:23888"},{"id":"T22154","span":{"begin":115,"end":125},"obj":"CHEBI:35222;CHEBI:35222"},{"id":"T69545","span":{"begin":139,"end":154},"obj":"CHEBI:52217;CHEBI:52217"}],"text":"in terms of antiviral activity and alleviation of disease symptoms, however drug combination is also an option for inhibitors with optimal pharmacokinetic properties that all"}